The Sustainable CEO: A New Way to Work in Peri & Menopause Workshop

Workplace Menopause Crisis

Menopause and perimenopause have surged into focus amid demographic shifts and policy changes. Women aged 45-54 now form the fastest-growing workforce segment in many nations, yet symptoms like hot flashes, sleep disruption, and cognitive fog erode productivity. In 2025, the UK's Employment Rights Bill introduced phased requirements for Menopause Action Plans, voluntary from April 2026 and mandatory for firms with 250+ staff by spring 2027. This responds to unmanaged symptoms costing £1.5 billion annually in lost output.

The impact hits hardest on vulnerable groups. Studies show non-college-educated women and those in routine-intensive roles suffer steeper declines, with earnings falling 10% four years post-symptom onset. Globally, menopause drives $150 billion in productivity losses, including $26 billion in US medical and work absences. Replacement costs for a £25,000-earning employee reach £30,500, underscoring the financial stakes.

Stakes include deadlines like the UK's 2027 mandate and consequences such as higher turnover—up to 14% of symptomatic women reduce hours or shift part-time. Inaction risks legal exposure under acts like the US Americans with Disabilities Act or emerging local laws, as in Philadelphia's 2025 protections. Broader effects ripple to economies, with 1.2 billion women projected postmenopausal by 2030.

Non-obvious angles reveal trade-offs. Sticky statistics blur whether women leave jobs or the workforce entirely, complicating policy. Caregiving burdens, disproportionately borne by women (76% globally), exacerbate symptoms, especially for Black women in informal roles. Counterarguments note weak evidence linking symptoms directly to exits, yet initiatives like Astellas' 2025 pledge show open dialogue boosts retention without high costs.